Is Chipotle Mexican Grill (CMG) Back on Track?

Chipotle Mexican Grill, Inc. (NYSE:CMG) dropped in the month of July, peaking at above $400 per share and finishing the month below $300, as its quarterly report indicated that it might not meet the aggressive growth trajectory that the Street and investors expected. However, the stock has popped 19% over the last month and a half and now is actually up for the year (though underperforming the broader market). Chipotle, which made our list of the ten most popular restaurant stocks among hedge funds for the second quarter of the year (see the full list), offers investors an appealing growth play in what has been a surprisingly fast-growing industry over the past few years. In addition, market research firm ITG recently announced that it believes that Chipotle’s same store sales this quarter will beat sell-side estimates. If the restaurant can get its same-store growth going at a 6-8% rate as it opens new locations, this would indicate that its growth can be sustained for a considerable period of time before it starts to encounter the “Starbucks problem” and see new locations get much of their business by cannibalizing sales at existing locations.

RENAISSANCE TECHNOLOGIES

One hedge fund which had a position in the stock at the end of the second quarter was Renaissance Technologies, which was founded by billionaire Jim Simons. Renaissance reported a position of about 600,000 shares, a stake worth nearly $230 million at that time (find more stocks that Renaissance Technologies likes). Coatue Management, which was founded in 1999 by Tiger Cub Philippe Laffont, increased its position by 49% during the second quarter to a total of about 570,000 shares; this made Chipotle one of the fund’s top ten holdings according to its 13F (see more of Philippe Laffont’s stock picks).

Here’s how dependent Chipotle is on growth: the $100 drop in its stock price came following a quarter in which it reported revenue growth of 21% compared to the same period a year ago (same-store sales growth was 8% for the quarter versus the second quarter of 2011). Expenses rose as well, but margins were held in check and earnings rose by 61%. A little over half of cash flow from operations in the first half of the year was used to purchase leasehold improvements, property, and equipment, which resulted in the company investing more in growth than it did in the first half of 2011. Chipotle’s 10-Q estimated that it would open about 160 new restaurants this year, including the 87 it had already opened; this brought the total number of locations worldwide to 1,316 at the end of June. Chipotle also deserves mention for being almost entirely focused on the U.S., in contrast to other restaurants such as McDonald’s Corporation (NYSE:MCD) and Yum! Brands, Inc. (NYSE:YUM). However, at 42 times trailing earnings and 32 times forward earnings estimates, the stock seems quite high priced.

Yum and McDonalds have performed fairly modestly recently- in its most recent quarter Yum experienced low growth compared to the same period a year earlier, while McDonalds actually saw a decline in its business- but the flip side is that they trade at lower earnings multiples. Yum’s is 21 while McDonalds’s is 17; both are expected to see growth next year, putting both their forward P/Es in the teens. Two peers in the restaurant industry seeing high earnings growth- 19% and 23% last quarter versus a year ago, respectively- are Starbucks Corporation (NASDAQ:SBUX) and Panera Bread Co (NASDAQ:PNRA). These growth rates aren’t as impressive as Chipotle’s, but at least provide a better perspective as to how restaurant investors are pricing growth. Starbucks trades at 28 times trailing earnings while Panera’s trailing P/E is 33. Their forward P/E multiples cluster around 24, still well below Chipotle’s but making the burrito restaurant’s valuation appear a bit more reasonable compared to the rest of the industry. It seems to us that all three of these growth-oriented restaurants may be too aggressive on the valuation front and we’d like to see their prices drop lower before considering them as buys.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!